Literature DB >> 12602674

Antibody response in common variable immunodeficiency.

Waleed Al-Herz1, Stephen J McGeady.   

Abstract

BACKGROUND: Common variable immunodeficiency (CVID) describes a heterogeneous group of immunologic disorders of unknown etiology. It is characterized by low levels of serum immunoglobulin (Ig) and impaired antibody response.
OBJECTIVE: To describe antibody response and the kinetics of IgG decline in patients identified with CVID.
METHODS: Clinical and immunologic observations of four patients identified with CVID were obtained by chart review.
RESULTS: Antibody response to polysaccharide antigens in patients identified with CVID is lost earlier than the antibody response to protein antigens, which may be preserved even in the face of profound hypogammaglobulinemia. In three patients who were followed prospectively, the Ig loss was progressive.
CONCLUSIONS: Absence of antibody response to polysaccharide antigens may be a universal finding in patients with CVID, whereas preservation of T cell-dependent protein antibody response may be seen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602674     DOI: 10.1016/S1081-1206(10)62149-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  6 in total

1.  Arthritis as a presenting symptom in a hypogammaglobulinemic patient with thymectomy.

Authors:  Omür Ardeniz; Sezgin Vatansever; Uğur Musabak; Kenan Aksu; Aytül Sin; Ali Kokuludağ
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

2.  Altered spectrum of somatic hypermutation in common variable immunodeficiency disease characteristic of defective repair of mutations.

Authors:  Bhargavi Duvvuri; Venkata R S K Duvvuri; Jörg Grigull; Alberto Martin; Qiang Pan-Hammarström; Gillian E Wu; Mani Larijani
Journal:  Immunogenetics       Date:  2010-10-12       Impact factor: 2.846

Review 3.  Clinical immunology in practice, new opportunities.

Authors:  Mark R Stein
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

4.  Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.

Authors:  D Tuerlinckx; F Vermeulen; V Pékus; G de Bilderling; Y Glupczynski; S Collet; J Jamart; E Bodart; F Mascart
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

5.  Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.

Authors:  Nima Rezaei; Seyed Davar Siadat; Asghar Aghamohammadi; Mostafa Moin; Zahra Pourpak; Dariush Norouzian; Jalal Izadi Mobarakeh; Mohammad Reza Aghasadeghi; Mehdi Nejati; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

6.  Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.

Authors:  Daniel Arroyo-Sánchez; Oscar Cabrera-Marante; Rocío Laguna-Goya; Patricia Almendro-Vázquez; Octavio Carretero; Francisco Javier Gil-Etayo; Patricia Suàrez-Fernández; Pilar Pérez-Romero; Edgard Rodríguez de Frías; Antonio Serrano; Luis M Allende; Daniel Pleguezuelo; Estela Paz-Artal
Journal:  J Clin Immunol       Date:  2021-11-17       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.